is isn an aquistion target at this level?, page-33

rab, it may not even be Myhundreds the way he is going!

I have been following this company and thread for about 4 or 5 months now and I have been trying to establish whether this product/stock warrants my investment, so far I would have to say no.

The product seems fine to me, and it looks like it works to some extent, but the real question for me is, is it good enough to disrupt Asthma sufferers current preventative measures and treatments? I mean does it really do anything earth shattering that will make a large amount of sufferers buy this product? Well so far I am coming up with no.

A product like this would need to deeply penetrate the market both here in Australia and in America to really make some decent money and imo it is a long way from doing that.

A quick look at the Asthma statistics in Australia shows that around 10% (2.26 million) of the population are Asthma sufferers, from here around 40% (904,000) are in the really juicy target range of 0-19yrs old. I think that if ISN could penetrate 30% (271,200) of this target market they would have done an outstanding job. At $100 odd a device we are looking at imo an absolute hit it out of the park best case scenario $27 million in one off payments and then a possible ongoing $542,000 per month or $6.5 million per year
in monthly fee's for the app.

For me those numbers do not really warrant my investment in a company with a market cap somewhere around $100 million already. IMO the risks of the market not actually taking up this device far outweigh the limited upside from the current price. For me if the sp gets back to the $0.10 - $0.15 range I may re-assess whether it is worth a punt, and at this stage that's all it would be.